mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?

Veerle P W M Wijtvliet, Kevin K Ariën, Steven Abrams, Marie M Couttenye, Fabienne Mestrez, Joachim Mariën, Benedicte Y De Winter, Pierre Van Damme, Lissa Pipeleers, Karl Martin Wissing, Daniel Abramowicz, Kristien J Ledeganck

Research output: Contribution to journalA1: Web of Science-article

Original languageEnglish
JournalNephrology, Dialysis, Transplantation
Volume37
Issue number4
Pages (from-to)799-803
Number of pages5
ISSN0931-0509
DOIs
Publication statusPublished - 2022

Keywords

  • 2019-nCoV Vaccine mRNA-1273
  • Antibodies, Viral
  • BNT162 Vaccine
  • COVID-19 Vaccines
  • Humans
  • Kidney Transplantation
  • Renal Dialysis
  • Transplant Recipients

Cite this